The available evidence showing that B7-H3 and CSPG4 are highly expressed in human ATC cell lines and tumors with a limited distribution on adjacent normal thyroid tissue, prompted us to investigate the antitumor efficacy of our CAR T cell therapies with thyroid cancers, including ATC [9, 10, 27]. This evidence concerns the gene CD276 and thyroid gland carcinoma.